According to Chun-Yan Sun [9], hsa-miR-15a acts as a putative tumor suppressor by targeting the oncogene B-cell lymphoma (BCL-2), which has been implicated in apoptosis and proliferation. The gene discussed is BCL2; the disease is neoplasm.